Drug Profile
Research programme: antibacterials - Indena
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Indena
- Class Benzofurans
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in Italy
- 28 Oct 2008 Preclinical trials in Bacterial infections in Italy (unspecified route)